Literature DB >> 26916845

Chemical composition and antifungal potential of Brazilian propolis against Candida spp.

I A Freires1, V C P P Queiroz1, V F Furletti2, M Ikegaki3, S M de Alencar4, M C T Duarte2, P L Rosalen5.   

Abstract

Propolis is known to have biological properties against numerous microorganisms of clinical interest. This study aimed to determine the chemical composition and antifungal activity of Brazilian propolis (types 3 and 13) against Candida spp. and their effects on the morphology of preformed and mature Candida biofilms. Samples of propolis (3 and 13) collected by Apis mellifera honeybees were obtained from different regions in Brazil. Ethanolic extracts of propolis (EEP) were prepared, fractionated and submitted to chemical analysis by GC/MS. The extracts and their hexane, dichloromethane and ethyl acetate fractions were tested for their ability to inhibit Candida spp. (C. albicans, C. dubliniensis, C. glabrata, C. kruzei, C. tropicalis and C. parapsilosis) by determination of the minimum inhibitory and fungicidal concentrations (MIC/MFC). Additionally, their effects on morphology of preformed and mature biofilms were observed by scanning electron microscopy. The phenolic compounds p-coumaric acid, caffeic acid phenethyl ester (CAPE), kaempferol and quercetin were identified in the EEP-3 and its bioactive dichloromethane fraction; and isoflavonoids such as medicarpin, vestitol and formononetin were found in the EEP-13, and triterpenes in its bioactive hexane fraction. The EEP-3 and EEP-13 and their bioactive fractions showed MIC values ranging from 0.2 to 125μg/mL and MFC values between 125 and 500μg/mL. The EEP and fractions were predominantly fungistatic agents. All extracts and fractions disrupted biofilm structures at 500μg/mL and amorphous areas with cell damage were clearly observed in preformed and mature biofilms. Propolis types 3 and 13 have strong anti-Candida activity and should be considered as promising candidates to treat oral and systemic candidiasis.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Biofilms; Candida; Candidiasis; Candidose; Isoflavonoids; Isoflavonoïdes; La propolis; Propolis

Mesh:

Substances:

Year:  2016        PMID: 26916845     DOI: 10.1016/j.mycmed.2016.01.003

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  15 in total

Review 1.  Therapeutic Properties of Bioactive Compounds from Different Honeybee Products.

Authors:  Laura Cornara; Marco Biagi; Jianbo Xiao; Bruno Burlando
Journal:  Front Pharmacol       Date:  2017-06-28       Impact factor: 5.810

2.  A complex game of hide and seek: the search for new antifungals.

Authors:  Huy X Ngo; Sylvie Garneau-Tsodikova; Keith D Green
Journal:  Medchemcomm       Date:  2016-05-17       Impact factor: 3.597

Review 3.  The Effects of Nutraceuticals and Herbal Medicine on Candida albicans in Oral Candidiasis: A Comprehensive Review.

Authors:  Fateme Gharibpour; Farinaz Shirban; Mohammad Bagherniya; Mohsen Nosouhian; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Interspecies Interactions between Clostridium difficile and Candida albicans.

Authors:  Pim T van Leeuwen; Jasper M van der Peet; Floris J Bikker; Michel A Hoogenkamp; Ana M Oliveira Paiva; Sarantos Kostidis; Oleg A Mayboroda; Wiep Klaas Smits; Bastiaan P Krom
Journal:  mSphere       Date:  2016-11-09       Impact factor: 4.389

5.  Novel Bi-Factorial Strategy against Candida albicans Viability Using Carnosic Acid and Propolis: Synergistic Antifungal Action.

Authors:  Alejandra Argüelles; Ruth Sánchez-Fresneda; José P Guirao-Abad; Cristóbal Belda; José Antonio Lozano; Francisco Solano; Juan-Carlos Argüelles
Journal:  Microorganisms       Date:  2020-05-16

6.  Antifungal Activity and Synergism with Azoles of Polish Propolis.

Authors:  Katarzyna Gucwa; Barbara Kusznierewicz; Sławomir Milewski; Patrick Van Dijck; Piotr Szweda
Journal:  Pathogens       Date:  2018-06-19

7.  The Effect of Iranian Propolis on Glucose Metabolism, Lipid Profile, Insulin Resistance, Renal Function and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Clinical Trial.

Authors:  Mehrnoosh Zakerkish; Maryam Jenabi; Narjes Zaeemzadeh; Ali Asghar Hemmati; Niloofar Neisi
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

8.  Susceptibility of Malassezia pachydermatis Clinical Isolates to Allopathic Antifungals and Brazilian Red, Green, and Brown Propolis Extracts.

Authors:  Kathleen Ramos Deegan; Maisa Santos Fonseca; Diogo Coelho Pádua Oliveira; Laerte Marlon Santos; Clara Couto Fernandez; Samira Abdallah Hanna; Bruna Aparecida Souza Machado; Marcelo Andrés Umsza-Guez; Roberto Meyer; Ricardo Wagner Portela
Journal:  Front Vet Sci       Date:  2019-12-13

Review 9.  Proteus mirabilis Biofilm: Development and Therapeutic Strategies.

Authors:  Reham Wasfi; Samira M Hamed; Mai A Amer; Lamiaa Ismail Fahmy
Journal:  Front Cell Infect Microbiol       Date:  2020-08-14       Impact factor: 5.293

10.  Evidence-Based Studies and Perspectives of the Use of Brazilian Green and Red Propolis in Dentistry.

Authors:  Claudemir de Carvalho; Wesley Henrique Cabral Fernandes; Thays Barreto Freitas Mouttinho; Daniela Martins de Souza; Maria Cristina Marcucci; Paulo Henrique Perlatti D'Alpino
Journal:  Eur J Dent       Date:  2019-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.